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On a broad national basis. it should be quite 
possible to substantially reduce maternal morbidity 
and the disproportionately high numbers of perinatal 
losses associated with diabetic pregnancies. Nation­
wide, the overall perinatal mortality rate for this 
group is approximately 20%. which is at least double 
that incurred in centers where intensive care facilities 
and personnel are available. and consistent, well­
coordinated care by the health team is provided. 
Although the prognosis for fetal survival is less 
favorable with advances in severity of the diabetic 
state. there is a significant risk even during the 
mildest stage of the disease. Careful prospective 
studies. notably those of O'Sullivan and his group. 
have demonstrated that gestational diabetics have a 
higher than normal perinatal mortality. Prevention 
begins with diagnosis. 
Detection. Ideally, a two-hour postprandial 
screening of blood sugar following a 100 g 
carbohydrate-equivalent breakfast should be a stan­
dard prenatal laboratory test. In practicality. all 
patients with a poor obstetric history, previous 
perinatal losses, large babies, a family history of 
diabetes. glycosuria, or significant obesity are can­
didates for a glucose tolerance test. Using these 
criteria, we subjected 3,340 prenatal patients to the 
three-hour glucose tolerance test following a 100 g 
glucose load, and 540 showed abnormal responses. 
The yield of positives, therefore, was I in 6.3 suspects, 
and the overall incidence of gestational diabetes in 
this Philadelphia population was 1.18%. Criteria used 
are as follows: fasting = 90 mg %: I hour = 165 mg 
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%: 2 hour = 145 mg %: 3 hour = 125 mg%. Glucose 
tolerance is impaired if two or more of these values 
are equaled or exceeded. The test is performed on 
whole blood using the Somogyi method or 
autoanalyzer (Hoffman) method. If plasma or serum 
is used. 10 mg % should be added to each of the 
values. The importance of a very large screening 
program was shown in the prospective study con­
ducted by O'Sullivan and his group who found that 
screening is particularly important in the obese, 
older-age patient. Perinatal mortality was 1.5% for 
normal control patients and 6.4% for those with 
gestational diabetes. The increase in perinatal loss 
was strikingly evident in gestational diabetic mothers 
25 years of age or older, with the risk further in­
creased by obesity. 
Metabolic Control. How strict should this be'1 
These patients are ketosis prone. Ketosis is one of the 
most lethal events for the fetus. but one of the most 
preventable complications for the mother. The in­
cidence of intrauterine fetal death is greatly increased 
in pregnancies complicated by pre-coma maternal 
acidosis. Of further concern is the fact that the 
National Collaborative Study reveals a significant 
relationship between maternal ketonuria and central 
nervous system defects or deficiencies in the off­
spring. Neither insulin treatment nor hypoglycemia 
shows a positive association. For these reasons the 
patient should be kept as nearly normoglycemic as 
possible and free of ketonuria even at the expense 
of an occasional episode of hypoglycemia which is 
readily controlled. 
Many, but not all, gestational diabetics can be 
maintained on diet alone. The response to diet is 
determined on the basis of a two-hour postprandial 
blood sugar obtained at two-week intervals. If the 
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two-hour value on diet cannot be maintained below 
160 mg%, the patient needs insulin, and for the pur­
pose of management of the pregnancy such patients 
should be considered in the insulin-dependent cate­
gory. 
Is there any advantage in treating all gestational 
diabetics with low-dose insulin? Several groups in this 
country and abroad have compared treated and un­
treated cases. Apart from slight reduction in over­
sized infants, other advantages are not yet sufficiently 
clear-cut to warrant recommending this approach. 
Oral hypoglycemic agents should not be used in 
pregnancy. In contrast to insulin, the sulfonyl ureas 
pass the placental barrier readily. Neonatal hepatic 
function is relatively immature, and the newborn 
metabolizes these drugs poorly. Intractable 
hypoglycemia persisting as long as the eleventh day 
of life, and in some instances requiring exchange 
transfusion, have been reported, particularly in rela­
tion to long-acting preparations such as chlor­
propamide. The biguanides which raise the blood lac­
tate level may accentuate the tendency to maternal 
ketoacidosis and are contraindicated during pregnan­
cy. 
The anti-insulin effects of pregnancy usually 
cause significant changes in insulin needs after the 
20 th week of gestation. The rise in requirement is 
sometimes precipitous about the 24th to 26th week. 
Both the patient and the physician should be on the 
lookout for these changes. In our patients, 75% needed 
a mean of about 60% more insulin. Twenty-three 
percent showed only minor increase in insulin 
requirement. Only an occasional patient showed 
reduction in insulin need. 
One of the poorly understood problems has to 
do with remission, which may occur particularly in 
the early stages of diabetes. How does one handle the 
patient who states that she had an abnormal glucose 
tolerance test with her previous pregnancy and was 
treated accordingly, but the glucose tolerance test in 
the present pregnancy is normal? While it is the rule 
that the diabetic state will progress, remissions do oc­
cur. We have encountered this phenomenon in a 
number of gestational diabetics and in one case of 
juvenile diabetes. Since the adverse ef
f
ect upon the 
fetus can occur al any stage including the prediabetic 
period, it is important to accept the reality of remis­
sion and to avoid the temptation to ascribe its oc­
currence to faulty initial diagnosis. 
Most diabetics have some degree of hydramnios, 
excessive in approximately 10% of cases. The com-
mon practice of prophylactic use of diuretic and 
rigid salt restriction may do more harm than good. 
Thiazides are useful only in otherwise uncompli­
cated fluid retention. If administered alternately 
three days on and three days off, these drugs will 
often reverse simple fluid shifts without disturbing 
electrolyte balance, but they are ineffectual for re­
versal of toxemia or hydramnios. Hospitalization 
is necessary if these conditions develop. Asympto­
matic bacteriuria is found in about 12 or 13% of 
diabetic pregnancies, or approximately twice the 
overall incidence, and should be treated when 
found. 
Prenatal Monitoring. The ability to predict in­
trauterine fetal deaths in diabetic pregnancies on 
clinical evidence alone has limitations. A reliable 
method for assessing intrauterine fetal welfare should 
be available in every diabetic pregnancy. Although 
no single test is capable of detecting all types of 
malfunctions that affect the fetus, the urine estriol 
test is, in our experience, indispensable. The fact 
that estriol production requires a fetal as well as a 
placental component is an obvious advantage. The 
types of cases in which estriol values may be mis­
leading are small in number and can usually be 
readily identified. These are mainly cases in which 
renal function is markedly reduced and renal clear­
ance of estriol diminished. 
Although the majority of patients with mild 
diabetes can be maintained free of complications and 
await labor at term, some cannot. Fetal deaths do oc­
cur in the virtually asymptomatic, well-controlled 
gestational diabetic pregnancy. In these cases, estriol 
determinations have proved to be of great value in 
identifying the fetus in jeopardy who should be 
delivered and, on the other hand, in providing 
reassurance and safe conduct through the natural 
course of pregnancy when estriol values remain in the 
normal range. 
Recent recommendations have been made to 
apply the same principles to pregnancies complicated 
by overt diabetes. While it is feasible to individualize 
and extend the timing of delivery to the 38th week 
or even beyond in many cases of B and C insulin­
dependent diabetics, those with advanced disease are 
poor candidates for this approach, even with frequent 
monitoring. From a practical point of view, and 
purely on clinical grounds, pregnancy in a patient 
with angiopathy, retinopathy, or nephropathy can 
rarely be carried beyond the 37th week, and all too 
often the pregnancy has to be terminated before that 
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optimal time in the interest of the mother or baby or 
both. The suddenness with which serious changes or 
events can take place in these patients and the fact 
that methods for determining fetal maturity are 
available (particularly the lecithin/sphingomyelin 
ratio and the creatinine concentration) offset the 
possible advantages of attempting to extend the 
gestational period for Classes D. E. and F diabetics 
beyond 37 weeks. 
The infant of a diabetic mother is at risk from 
the moment of birth. Respiratory distress is the 
greatest threat. It is most directly related to 
prematurity and accentuated in diabetes. While tests 
for fetal maturity should make iatrogenic prematuri­
ty preventable, early delivery will continue to be 
necessary in selected cases to avoid intrauterine fetal 
death or damage. The neonatologist experienced in 
dealing with respiratory pathophysiology who can 
initiate treatment within minutes after birth, and a 
neonatal intensive care unit capable of providing 
clinical and laboratory support services on a 24-
hour-a-day basis offer the best chance for intact 
survival. 
In principle. the problems of diabetic pregnan­
cies do not differ from the problems of at least two­
thirds of all high-risk pregnancies, and in this respect, 
they serve as a prototype for centralized perinatal 
care. The demands in terms of medical and 
paramedical manpower. the high cost of services and 
facilities comprising the perinatal center, and the con­
cern for quality of life will surely require revision of 
the current health care delivery system. Consolida­
tion of scarce resources in centers. whether teaching 
or community hospitals. capable of providing 
specialized care for the high-risk mother and new­
born is the logical approach. 
